Kristen Bunnell Bresnehan, PharmD, BCCCP

Associate Professor, Department of Clinical Sciences

Locations

MCW Pharmacy School
HRC H2600

Contact Information

Education

PharmD, Northeastern University, Boston, Massachusetts
Fellowship, Infectious Diseases Pharmacotherapy, University of Illinois at Chicago, Chicago, IL
PGY-2 Critical Care Specialty Residency, Virginia Commonwealth University, Richmond, VA
PGY-1 Pharmacy Practice Residency, Seton Family of Hospitals and the University of Texas at Austin, Austin, TX
Teaching Certificate, Virginia Commonwealth University School of Pharmacy, Richmond, VA

Certifications

Clinical Research Methods certificate program, University of Illinois at Chicago School of Public Health
Board Certification in Critical Care Pharmacotherapy, Board of Pharmacy Specialties
Advanced Cardiovascular Life Support, American Heart Association
Registered Pharmacist; Illinois, Texas

Biography

Kristen Bunnell Bresnehan, PharmD, BCCCP, joined the MCW Pharmacy School as an assistant professor in July 2017. Prior to her appointment, she was a research fellow in infectious diseases pharmacotherapy and pharmacokinetics at the University of Illinois at Chicago College of Pharmacy. Dr. Bunnell Bresnehan's postgraduate training included a pharmacy practice residency and specialty residency in critical care, and she practiced for several years as a clinical pharmacy specialist in the trauma/burn intensive care unit at an academic health system in Rhode Island prior to her fellowship. Her clinical and research interests include critical care, infectious diseases, HIV management in the acute care and ambulatory settings, pain management, and emergency medicine.

Research Experience

Gram-Negative Bacterial Infections
Gram-Positive Bacterial Infections
Pharmacokinetics
Pneumonia, Ventilator-Associated
Renal Replacement Therapy

Clinical Expertise

Antimicrobial Stewardship
Critical Care
Infectious Disease Medicine
Travel Medicine

Research Interests

Pharmacokinetic alterations in critical illness, obesity, renal impairment and renal replacement therapy
Antimicrobial pharmacokinetics and pharmacodynamics
Pain, agitation and delirium in the intensive care unit

Virologic outcomes of antiretroviral therapy in patients with HIV-1 following bariatric surgery: A case series and review of the literature

(Badowski M, Kassem S, Labedz M, Taylor C, Bunnell K, Hall A, Darnell H, Huesgen E.) International Journal of STD and AIDS. February 2024;35(2):103-111 SCOPUS ID: 2-s2.0-85176223253 02/01/2024
Oral antibiotic step-down therapy for nonstaphylococcal gram-positive bloodstream infections

(Gandhi K, Wrzesinski M, Bunnell K, Gibble A.) Diagnostic Microbiology and Infectious Disease. December 2023;107(4) SCOPUS ID: 2-s2.0-85172656301 12/01/2023
Viral myocarditis

(Schmidt AL, Maistelman E, Bunnell K..) Journal of the Pharmacy Society of Wisconsin. JPSW July-August 2022 07/15/2022
Aminopenicillins for treatment of ampicillin-resistant enterococcal urinary tract infections.

(Bunnell K, Duong A, Ringsred T, Mian A, Bhathena S.) Am J Health Syst Pharm. 2022 Jun 23;79(13):1056-1065 PMID: 35299243 SCOPUS ID: 2-s2.0-85133100597 03/18/2022
Tebipenem pivoxil hydrobromide: review of a new oral carbapenem in development.

(Roig J, Sorenson J, Staffin M, Amrhein A, Bunnell K..) Journal of the Pharmacy Society of Wisconsin. JPSW May-June 2021 05/15/2021
Pain in the patella: updates in the management of osteomyelitis.

(Long A, Bevry M, Wellborn A, Bunnell K. .) Journal of the Pharmacy Society of Wisconsin. JPSW May-June 2020 05/15/2020
Chloroquine and hydroxychloroquine: what does the evidence say for use in COVID-19?

(Bunnell K, Revolinski S, Wainaina N..) Journal of the Pharmacy Society of Wisconsin. JPSW May-June 2020 05/15/2020
Ex Vivo Urinary Bactericidal Activity and Urinary Pharmacodynamics of Fosfomycin after Two Repeated Dosing Regimens of Oral Fosfomycin Tromethamine in Healthy Adult Subjects.

(Wenzler E, Meyer KM, Bleasdale SC, Sikka M, Mendes RE, Bunnell KL, Finnemeyer M, Rosenkranz SL, Danziger LH, Rodvold KA.) Antimicrob Agents Chemother. 2020 Jan 27;64(2) PMID: 31767717 PMCID: PMC6985713 SCOPUS ID: 2-s2.0-85078572928 11/27/2019
Association Between Estimated Pharmacokinetic/Pharmacodynamic Predictions of Efficacy and Observed Clinical Outcomes in Obese and Nonobese Patients With Enterobacteriaceae Bloodstream Infections.

(Santibañez M, Bunnell K, Harrington A, Bleasdale S, Wenzler E.) Open Forum Infect Dis. 2019 Oct;6(10):ofz400 PMID: 31660362 PMCID: PMC6790397 SCOPUS ID: 2-s2.0-85084500006 10/30/2019
New Antimicrobials Expand Treatment Options

(Woulfe E, Vu T, Schaack H, Dyer J, Bunnell K.) Pharmacy Times Health Systems Edition. September 2019, Volume 8, Issue 5 09/24/2019
Get PrEPared for HIV Prophylaxis

(Solofra C, Sanok R, Lindstrom R, Bunnell K.) Pharmacy Times Health Systems Edition. May 2019 Volume 8 Issue 3 06/03/2019
Phase I Study To Evaluate the Pharmacokinetics, Safety, and Tolerability of Two Dosing Regimens of Oral Fosfomycin Tromethamine in Healthy Adult Participants.

(Wenzler E, Bleasdale SC, Sikka M, Bunnell KL, Finnemeyer M, Rosenkranz SL, Danziger LH, Rodvold KA, Antibacterial Resistance Leadership Group.) Antimicrob Agents Chemother. 2018 Aug;62(8) PMID: 29891606 PMCID: PMC6105781 SCOPUS ID: 2-s2.0-85052025758 06/13/2018

My goal as an educator is not only to provide knowledge that transcends the scope of a textbook, but also to foster skills that students will need to be competent future clinicians. Since we can’t always bring the class to the bedside, this is best accomplished by bringing the bedside to the classroom- ultimately, optimizing patient outcomes is the foundation of our practice.

Kristen Bunnell, PharmD, BCCCP

July 2017